The Current Ratio as of November 2024 (TTM) for Defence Therapeutics Inc. (DTCFF) is 0.05

According to Defence Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.05. This represents a change of -95.03% compared to the average of 1.06 of the last 4 quarters.

Defence Therapeutics Inc. (DTCFF) Historical Current Ratio (quarterly & annually)

How has DTCFF Current Ratio performed in the past?

The mean historical Current Ratio of Defence Therapeutics Inc. over the last ten years is 16.89. The current 0.05 Current Ratio has changed -68.72% with respect to the historical average. Over the past ten years (40 quarters), DTCFF's Current Ratio was at its highest in in the December 2020 quarter at 94.21. The Current Ratio was at its lowest in in the September 2019 quarter at 0.

Defence Therapeutics Inc. (DTCFF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Defence Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Defence Therapeutics Inc. (DTCFF) Average Current Ratio

How has DTCFF Current Ratio performed in the past?

The current Current Ratio of Defence Therapeutics Inc. (DTCFF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Defence Therapeutics Inc. (DTCFF) Current Ratio vs. Peers

How is DTCFF’s Current Ratio compared to its peers?

Defence Therapeutics Inc.’s Current Ratio is less than Sino Biopharmaceutical Limited (1.15), greater than Institute of Biomedical Research Corp. (0), less than Aileron Therapeutics, Inc. (4.69), less than Enlivex Therapeutics Ltd. (10.06), greater than Panbela Therapeutics, Inc. (0.05), less than Lixte Biotechnology Holdings, Inc. (6.33), less than Benitec Biopharma Inc. (10.49), less than Cingulate Inc. (1.20), less than TRACON Pharmaceuticals, Inc. (0.66), less than XOMA Corporation (8.71), less than Fortress Biotech, Inc. (1.37), less than Checkpoint Therapeutics, Inc. (0.26), less than ZIVO Bioscience, Inc. (0.17), less than Lumos Pharma, Inc. (4.23), less than Apellis Pharmaceuticals, Inc. (0), less than Terns Pharmaceuticals, Inc. (5.08), less than Day One Biopharmaceuticals, Inc. (21.02), less than Blueprint Medicines Corporation (14.62), less than Cerevel Therapeutics Holdings, Inc. (3.32), less than null (10.22),

Build a custom stock screener for Defence Therapeutics Inc. (DTCFF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Defence Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Defence Therapeutics Inc. (DTCFF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Defence Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.